ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

NCI Renews City of Hope’s Comprehensive Cancer Center Designation.

May 30, 2008

In Brief: Des Exposed Women Face New Risk: Unfavorable Pregnancies; Hutchinson Labor Election Set

March 21, 1980

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010